ISSCR News
The ISSCR Shared Comments on Hong Kong’s Draft Guidance for Cell and Tissue Products
The ISSCR condemns the premature commercialization of unproven cell therapies, which has resulted in patients being blinded, paralyzed, and infected with dangerous pathogens. In many countries, unscrupulous businesses marketing these unproven cell therapies have abused ambiguous definitions for substantial/minimal manipulation and homologous use to claim they are not subject to oversight. Regulators around the world need to adopt harmonized product definitions to protect public health and to prevent the premature commercialization of stem cell-based products.
The ISSCR Signs Ad Hoc Group for Medical Research Coalition Letter on NIH to President-elect Biden
The ISSCR joined with the Ad Hoc Group for Medical Research and 349 member organizations representing patients, clinicians, scientists, educators, academic institutions, research organizations, and industry, in a letter thanking President-elect Joseph R. Biden, Jr. for his steadfast support for science. The letter states, "As the oldest coalition advocating for the federal investment in the National Institutes of Health (NIH) and biomedical, bioengineering, behavioral, and social science research, we are grateful that you support increased and sustainable funding growth for the NIH as part of $300 billion in new research and development investments in your Build Back Better plan."
Member Spotlight: Joshua Currie, PhD
“Experiencing the entire breadth of the ISSCR during the annual meetings makes me proud to be a society member. To see the translational work, fundamental science breakthroughs, and public policy and ethics advocacy is great inspiration”.
Member Spotlight: Kazuo Takayama, PhD
“Enjoy your research! Research that cannot be enjoyed is difficult to continue. If the current situation is difficult, it is important to change the research theme or the laboratory”.
ISSCR Global Science Advocacy: Your Voice for Policies Affecting Stem Cell Research
I have long believed that one of the most valuable benefits of your membership is the opportunity to leverage the expertise of the global stem cell and regenerative medicine community to help ensure that legislative and regulatory policies support responsible research and discovery in our field. A substantial amount of scientific research is funded through national or government investment, therefore these policies can have a significant impact on biomedical research and the pursuit of new therapeutics to treat disease.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .